Lutein/Zeaxanthin in AREDS2 May Slow Progression to Late AMD

FRIDAY, June 10, 2022 -- For individuals with age-related macular degeneration (AMD), the addition of lutein/zeaxanthin to the Age-Related Eye Disease Study 2 (AREDS2) supplement appears to be safe, according to a study published online June 2 in...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news